enteralogo.png
Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
November 29, 2023 08:30 ET | Entera Bio Ltd.
JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, reported...
tiziana-logo.png
Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023
November 01, 2023 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
PharmAla Biotech Logo 800 x 422.png
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
September 25, 2023 08:55 ET | PharmAla Biotech
PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty
Synlogic_Logo_Blue.png
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
June 28, 2023 07:00 ET | Synlogic, Inc.
The World Health Organization has approved “labafenogene marselecobac”Name attributes recognize Synlogic’s proprietary technology and commitment to phenylketonuria communityCAMBRIDGE, Mass., June...
PharmAla Biotech Logo 800 x 422.png
PharmAla Awarded Research Grant by Ontario Centre for Innovation
June 09, 2023 13:18 ET | PharmAla Biotech
TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel...
sirona_logo.jpg
Sirona Biochem Engages Atheln Inc. to Strengthen Business Development Initiatives
May 25, 2023 09:00 ET | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is pleased to announce it has contracted Atheln Inc. ("Atheln"), a...
Replay_Logo_Black_CMYK.png
Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer
May 18, 2023 08:00 ET | Replay Bio
Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer Arun Balakumaran M.D., Ph.D, appointed Chief Medical Officer of Replay to support the Company’s genomic medicine and engineered...
sirona_logo.jpg
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy
May 11, 2023 09:00 ET | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the Investing News Network has...
sirona_logo.jpg
Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston
May 03, 2023 09:00 ET | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) ("Sirona") is excited to announce that Dr. Geraldine Deliencourt-Godefroy,...
Axiom-22 Anniversary Logo - Transparent.png
Axiom Exhibiting at Clinical Operations in Oncology Trials West Coast 2023
April 25, 2023 13:13 ET | Axiom Real-Time Metrics Inc
TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...